Genmetil MD Tablet is a fast-acting, orally disintegrating formulation containing Prochlorperazine (5mg), a trusted phenothiazine derivative widely used in the management of nausea, vomiting, vertigo, and certain psychiatric conditions such as anxiety and schizophrenia. It acts as a dopamine (D2) receptor antagonist, exerting its effects by regulating neurotransmitter activity in the brain and gastrointestinal tract.
Designed for ease of use, Genmetil MD offers rapid absorption through the oral mucosa, making it ideal for patients who experience difficulty swallowing or are actively vomiting. Its mechanism of action primarily targets the chemoreceptor trigger zone (CTZ) in the brain, reducing the sensation of nausea and controlling emesis effectively.
In addition to its antiemetic properties, Prochlorperazine is also beneficial in managing acute psychotic episodes, tension headaches, and vestibular disorders such as Ménière's disease. The medication stabilizes mood by modulating excessive dopamine activity, thereby reducing symptoms of restlessness, anxiety, and hallucinations.
The MD (mouth dissolving) format enhances patient compliance, especially in outpatient settings or during travel where nausea is sudden and oral medication may be difficult to retain. Genmetil MD is effective in both short-term and maintenance therapy under medical supervision.
Its broad clinical utility makes it a valuable component in managing various disorders related to the central nervous system and gastrointestinal tract, especially where nausea or dizziness is a primary complaint. The formulation is generally well-tolerated, but monitoring may be required for patients using it over extended periods or in higher doses.